Coronary Artery Calcium Staging to Guide Preventive Interventions: A Proposal and Call to Action.
作者信息
Maron David J, Budoff Matthew J, Sky Joseph C, Bommer William J, Epstein Sarah D, Fisher Dane A, Stock Eveline O, Taylor Allen J, Wong Nathan D, DeMaria Anthony N
机构信息
Stanford Prevention Research Center and Division of Cardiovascular Medicine, Department of Medicine and the Cardiovascular Institute, Stanford University, Stanford, California, USA.
Division of Cardiology, Lundquist Institute, Harbor-UCLA Medical Center, Torrance, California, USA.
出版信息
JACC Adv. 2024 Sep 24;3(11):101287. doi: 10.1016/j.jacadv.2024.101287. eCollection 2024 Nov.
Abstract
摘要
相似文献
1
Coronary Artery Calcium Staging to Guide Preventive Interventions: A Proposal and Call to Action.冠状动脉钙化分期以指导预防性干预：一项提议与行动呼吁。
JACC Adv. 2024 Sep 24;3(11):101287. doi: 10.1016/j.jacadv.2024.101287. eCollection 2024 Nov.
2
Contemporary use of coronary artery calcium for the allocation of aspirin in light of the 2022 USPSTF guideline recommendations.根据2022年美国预防服务工作组（USPSTF）指南建议，冠状动脉钙化在阿司匹林分配中的当代应用。
Am J Prev Cardiol. 2022 Nov 3;12:100427. doi: 10.1016/j.ajpc.2022.100427. eCollection 2022 Dec.
3
The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction.美国国家脂质协会关于冠状动脉钙评分指导 ASCVD 风险降低的预防策略的科学声明。
J Clin Lipidol. 2021 Jan-Feb;15(1):33-60. doi: 10.1016/j.jacl.2020.12.005. Epub 2020 Dec 11.
4
An Update on the Utility of Coronary Artery Calcium Scoring for Coronary Heart Disease and Cardiovascular Disease Risk Prediction.冠状动脉钙评分在冠心病和心血管疾病风险预测中的应用进展。
Curr Atheroscler Rep. 2016 Mar;18(3):13. doi: 10.1007/s11883-016-0565-6.
5
Preventive Interventions After Coronary Artery Calcium Scanning: Seeing is Believing.冠状动脉钙化扫描后的预防性干预措施：眼见为实。
JACC Cardiovasc Imaging. 2017 Aug;10(8):843-844. doi: 10.1016/j.jcmg.2017.02.025.
6
Use of coronary artery calcium score and coronary CT angiography to guide cardiovascular prevention and treatment.使用冠状动脉钙化积分和冠状动脉 CT 血管造影来指导心血管的预防和治疗。
Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447241249650. doi: 10.1177/17539447241249650.
7
Coronary Artery Calcium Versus Pooled Cohort Equations Score for Primary Prevention Guidance: Randomized Feasibility Trial.冠状动脉钙化与用于一级预防指导的合并队列方程评分：随机可行性试验。
JACC Cardiovasc Imaging. 2022 May;15(5):843-855. doi: 10.1016/j.jcmg.2021.11.006. Epub 2021 Dec 15.
8
Using coronary calcification scanning in the clinical practice of preventive cardiology.
J Cardiovasc Risk. 2000 Apr;7(2):121-3. doi: 10.1177/204748730000700206.
9
Integrating Coronary Atherosclerosis Burden and Progression with Coronary Artery Disease Risk Factors to Guide Therapeutic Decision Making.整合冠状动脉粥样硬化负担及进展与冠状动脉疾病危险因素以指导治疗决策
Am J Med. 2023 Mar;136(3):260-269.e7. doi: 10.1016/j.amjmed.2022.10.021. Epub 2022 Dec 10.
10
Computed tomography calcium scoring association and reclassification of clinical cardiovascular risk in asymptomatic Mexican patients.计算机断层扫描钙评分与无症状墨西哥患者临床心血管风险的关联及重新分类
SAGE Open Med. 2020 Jul 2;8:2050312120938233. doi: 10.1177/2050312120938233. eCollection 2020.
引用本文的文献
1
Identification and management of patients at high-risk for cardiovascular disease in primary prevention.初级预防中心血管疾病高危患者的识别与管理
Am J Prev Cardiol. 2025 Aug 22;23:101265. doi: 10.1016/j.ajpc.2025.101265. eCollection 2025 Sep.
2
LDL-C targets based on coronary artery calcium: advancing Figure 6 from the 2022 American college of cardiology expert consensus decision pathway.基于冠状动脉钙化的低密度脂蛋白胆固醇目标：推进2022年美国心脏病学会专家共识决策路径中的图6
Am J Prev Cardiol. 2025 Jun 26;23:101047. doi: 10.1016/j.ajpc.2025.101047. eCollection 2025 Sep.
3
A Critical Appraisal of Lipid Management in the Post-Statin Era: Comparison on Guidelines, Therapeutic Targets, and Screening in a Case-Based Framework of Lipid Management.他汀类药物时代后脂质管理的批判性评估：基于病例的脂质管理框架中指南、治疗靶点及筛查的比较
JACC Adv. 2025 Jun;4(6 Pt 2):101823. doi: 10.1016/j.jacadv.2025.101823.
4
Coronary artery calcium in a 20-year-old South Asian patient - pushing the limits of detecting "early disease".一名20岁南亚患者的冠状动脉钙化——挑战“早期疾病”检测的极限。
Am J Prev Cardiol. 2025 Jan 22;21:100935. doi: 10.1016/j.ajpc.2025.100935. eCollection 2025 Mar.
本文引用的文献
1
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association.纳入心血管-肾脏-代谢健康因素的全心血管疾病绝对风险评估新预测方程：美国心脏协会科学声明
Circulation. 2023 Dec 12;148(24):1982-2004. doi: 10.1161/CIR.0000000000001191. Epub 2023 Nov 10.
2
When Does a Calcium Score Equate to Secondary Prevention?: Insights From the Multinational CONFIRM Registry.钙评分何时等同于二级预防？来自多国CONFIRM注册研究的见解。
JACC Cardiovasc Imaging. 2023 Sep;16(9):1181-1189. doi: 10.1016/j.jcmg.2023.03.008. Epub 2023 May 24.
3
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee.2022年美国心脏病学会解决方案集监督委员会关于非他汀类疗法在降低低密度脂蛋白胆固醇以管理动脉粥样硬化性心血管疾病风险中的作用的专家共识决策路径报告。
J Am Coll Cardiol. 2022 Oct 4;80(14):1366-1418. doi: 10.1016/j.jacc.2022.07.006. Epub 2022 Aug 25.
4
Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association.《生命的基础 8：更新和强化美国心脏协会心血管健康构建：美国心脏协会主席特别咨询报告》。
Circulation. 2022 Aug 2;146(5):e18-e43. doi: 10.1161/CIR.0000000000001078. Epub 2022 Jun 29.
5
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
6
Socioeconomics of coronary artery calcium: Is it scored or ignored?冠状动脉钙化的社会经济学：评分还是忽略？
J Cardiovasc Comput Tomogr. 2022 Mar-Apr;16(2):182-185. doi: 10.1016/j.jcct.2021.10.003. Epub 2021 Oct 15.
7
Role of Coronary Artery Calcium Testing for Risk Assessment in Primary Prevention of Atherosclerotic Cardiovascular Disease: A Review.冠状动脉钙检测在动脉粥样硬化性心血管疾病一级预防中的风险评估作用：综述。
JAMA Cardiol. 2022 Feb 1;7(2):219-224. doi: 10.1001/jamacardio.2021.3948.
8
Very High Coronary Artery Calcium (≥1000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA.极高的冠状动脉钙（≥1000）与心血管疾病事件、非心血管疾病结局和死亡率的关系：来自 MESA 的结果。
Circulation. 2021 Apr 20;143(16):1571-1583. doi: 10.1161/CIRCULATIONAHA.120.050545. Epub 2021 Mar 2.
9
No-Charge Coronary Artery Calcium Screening for Cardiovascular Risk Assessment.免费冠状动脉钙化筛查用于心血管风险评估。
J Am Coll Cardiol. 2020 Sep 8;76(10):1259-1262. doi: 10.1016/j.jacc.2020.06.077.
10
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南：美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2019 Sep 10;74(10):e177-e232. doi: 10.1016/j.jacc.2019.03.010. Epub 2019 Mar 17.
Zotero 插件